Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 7, 2014; 20(25): 8061-8071
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8061
Clinical relevance of sarcopenia in patients with cirrhosis
Aldo J Montano-Loza
Aldo J Montano-Loza, Division of Gastroenterology and Liver Unit, University of Alberta Hospital, University of Alberta, Edmonton AB T6G 2X8, Canada
Author contributions: Montano-Loza AJ solely contributed to this paper.
Correspondence to: Aldo J Montano-Loza, MD, MSc, PhD, Assistant Professor, Division of Gastroenterology and Liver Unit, University of Alberta Hospital, University of Alberta, 130 University Campus, Edmonton AB T6G 2X8, Canada. montanol@ualberta.ca
Telephone: +1-780-2481892 Fax: +1-780-2481895
Received: November 1, 2013
Revised: January 13, 2014
Accepted: March 12, 2014
Published online: July 7, 2014
Abstract

The most commonly recognized complications in cirrhotic patients include ascites, hepatic encephalopathy, variceal bleeding, susceptibility for infections, kidney dysfunction, and hepatocellular carcinoma; however, severe muscle wasting or sarcopenia are the most common and frequently unseen complications which negatively impact survival, quality of life, and response to stressor, such as infections and surgeries. At present, D’Amico stage classification, Child-Pugh, and MELD scores constitute the best tools to predict mortality in patients with cirrhosis; however, one of their main limitations is the lack of assessing the nutritional and functional status. Currently, numerous methods are available to evaluate the nutrition status of the cirrhotic patient; nevertheless, most of these techniques have limitations primarily because lack of objectivity, reproducibility, and prognosis discrimination. In this regard, an objective and reproducible technique, such as muscle mass quantification with cross-sectional imaging studies (computed tomography scan or magnetic resonance imaging) constitute an attractive index of nutritional status in cirrhosis. Sarcopenia is part of the frailty complex present in cirrhotic patients, resulting from cumulative declines across multiple physiologic systems and characterized by impaired functional capacity, decreased reserve, resistance to stressors, and predisposition to poor outcomes. In this review, we discuss the current accepted and new methods to evaluate prognosis in cirrhosis. Also, we analyze the current knowledge regarding incidence and clinical impact of malnutrition and sarcopenia in patients with cirrhosis and their impact after liver transplantation. Finally, we discuss existing and potential novel therapeutic approaches for malnutrition in cirrhosis, emphasizing the recognition of sarcopenia in an effort to reduced morbidity related and improved survival in cirrhosis.

Keywords: Cirrhosis, Sarcopenia, Malnutrition, Prognosis, Mortality, Body composition, Lumbar skeletal muscle index, Liver transplantation

Core tip: Severe muscle wasting or sarcopenia is one of the most common and frequently hidden complications in patients with cirrhosis, which negatively impact survival, quality of life, and response to stressor, such as infections and surgeries. Numerous indirect methods have been used to quantify body composition in cirrhotics; however, most of these methods lack either availability and/or reproducibility, and their accuracy may be limited in the presence of fluid retention. Cross-sectional imaging studies, including computed tomography scan, or magnetic resonance imagingare the gold standard tools to quantify skeletal muscle mass and hence constitute a good resource for objective and detailed nutritional/metabolic assessment of cirrhotic patients and identification of sarcopenia.